Seres Therapeutics
MCRB
MCRB
123 hedge funds and large institutions have $313M invested in Seres Therapeutics in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 49 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
31% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 49
42% less capital invested
Capital invested by funds: $535M → $313M (-$222M)
Holders
123
Holding in Top 10
1
Calls
$788K
Puts
$659K
Top Buyers
| 1 | +$34.2M | |
| 2 | +$16.2M | |
| 3 | +$9.34M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
+$3.96M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.19M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$2.56M | |
| 3 | -$2.14M | |
| 4 |
Rafferty Asset Management
New York
|
-$2.11M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.6M |